IPRMT1

IPRMT1 is a potent and selective PRMT1 inhibitor for breast cancer research. iPRMT1 inhibits breast cancer cell growth in vitro and in vivo with EC50 values of 90, 70, and 9 nM in MCF7, T47D, and MDA-MB-231 cells, respectively[1].

Product Specifications

UNSPSC

12352005

Target

Histone Methyltransferase

Type

Reference compound

Related Pathways

Epigenetics

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/iprmt1.html

Solubility

10 mM in DMSO

Smiles

OC(CC1)CCN1C(C=C2)=CC=C2NC3=NC(N4[C@H]5CC6=CC=CC=C46)=C(C=N3)NC5=O

Molecular Formula

C24H24N6O2

Molecular Weight

428.49

References & Citations

[1]Li WJ, et al. Targeting PRMT1-mediated SRSF1 methylation to suppress oncogenic exon inclusion events and breast tumorigenesis. Cell Rep. 2023 Nov 7;42 (11) :113385.